CA2341400A1 — Methods and compositions employing optically pure s(+) vigabatrin
Assigned to Sumitomo Pharma America Inc · Expires 2000-03-02 · 26y expired
What this patent protects
Methods and compositions for the prevention, treatment, and/or management of the symptoms of peripheral neuropathy and related disorders, drug or alcohol addiction or the symptoms thereof, or symptoms associated with drug or alcohol withdrawal, using substantially optically pure …
USPTO Abstract
Methods and compositions for the prevention, treatment, and/or management of the symptoms of peripheral neuropathy and related disorders, drug or alcohol addiction or the symptoms thereof, or symptoms associated with drug or alcohol withdrawal, using substantially optically pure S(+) vigabatrin, or a pharmaceutically acceptable salt thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.